News

Richter-Helm Biologics and INOVIO will expand existing DNA manufacturing agreement to support large-scale manufacturing of Inovio’s investigational DNA vaccine for COVID-19
Richter-Helm Biologics, Gedeon Richter Plc. ("Richter") and Helm AG's joint...
Richter entered into an asset purchase agreement with Mycenax for the biosimilar tocilizumab
Gedeon Richter Plc. ("Richter") today announced that it has entered...
Richter launched Terrosa, its biosimilar teriparatide across Europe
Gedeon Richter Plc. ("Richter") today announced that it has launched...